3 Things About Moderna That The Smartest Investors Know
Moderna (NASDAQ: MRNA) has been one of the most talked-about stocks over the past year. The biotech company became the first to bring a coronavirus vaccine candidate into clinical testing -- and the second to bring a vaccine to market -- and using a new technology, to boot. That's why the company's shares also have been big movers over the past year and have climbed more than 140% during that time.
But there's more to Moderna than one-time vaccine sales and a quick share gain. Let's take a look at the three things about Moderna that the smartest investors know. (And that's why they're holding onto the shares.)
Image source: Getty Images.
Source Fool.com
